Susanne Schneider

Follow-up studies of long COVID in patients with Parkinson’s disease 1:48
Follow-up studies of long COVID in patients with Parkinson’s disease
Susanne Schneider • 19 Sep 2022
Evaluating the impact of COVID-19 on patients with movement disorders 2:26
Evaluating the impact of COVID-19 on patients with movement disorders
Susanne Schneider • 21 Sep 2022
How can patients with movement disorders receive adequate care and guidance? 1:34
How can patients with movement disorders receive adequate care and guidance?
Susanne Schneider • 19 Sep 2022
COVID-19 and movement disorders 3:54
COVID-19 and movement disorders
Susanne Schneider • 21 Sep 2022
Treatment options for dystonia: anticholinergics, levodopa, botulinum toxin and DBS 3:57
Treatment options for dystonia: anticholinergics, levodopa, botulinum toxin and DBS
Susanne Schneider • 17 Sep 2020
Challenges in diagnosing and treating dystonia 2:08
Challenges in diagnosing and treating dystonia
Susanne Schneider • 17 Sep 2020
The importance of genetic testing for diagnosing and treating dystonia 1:40
The importance of genetic testing for diagnosing and treating dystonia
Susanne Schneider • 17 Sep 2020
Dystonia: developments in diagnostics, genetics and treatment 2:49
Dystonia: developments in diagnostics, genetics and treatment
Susanne Schneider • 17 Sep 2020
The content of VJNeurology is intended for healthcare professionals